ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
Shanghai Zhongshan Hospital
AstraZeneca
Ankara Etlik City Hospital
AstraZeneca
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Centre Hospitalier Universitaire de Nice
AstraZeneca
CHA University
Royal Marsden NHS Foundation Trust
Viome
Seoul National University Hospital
Massachusetts General Hospital
Wake Forest University Health Sciences
Sahlgrenska University Hospital
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Cook Group Incorporated
Kansai Hepatobiliary Oncology Group
Kansai Hepatobiliary Oncology Group
Mauna Kea Technologies